Tag: cellular therapies
March 1, 2018
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2017 Financial Results
Intra-Cellular Therapies (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced... April 28, 2017
Sorrento's Cell Therapy Subsidiary Acquires Virttu
Sorrento Therapeutics announced its cell therapy subsidiary TNK Therapeutics completed the acquisition of Virttu Biologics. March 29, 2017